Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ALGN · against 1,336 other Healthcare companies
Ranked #369 of 1,337 · scores higher than 72% of peers
Bars: peers in each 10-point band of the valuation score134 peers with a valuation score of 70–79, including ALGN · Click a bar to see the companies
Mainly thanks to its free cash flow yield, EBITDA yield and earnings yield, which are stronger than most Healthcare peers.
| Metric | ALGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 3.8% | 1.5% | 69% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 9.5% | 4.2% | 78% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 5.9% | -1.0% | 83% | 20% | |
| Book yieldHigher is better · 1,306 reported | 39.2% | 37.9% | 52% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 369 | 1.21T JPY (≈$8.2B) | 72 | 74 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 369 | 384.1B KRW (≈$277M) | 72 | 40 |
| 369 | 7.5B CNY (≈$1.1B) | 72 | 82 |
| 369 | 47.8B HKD (≈$6.1B) | 72 | 60 |
| 369 | 10.8B USD | 72 | 54 |
| 369 | 157.8B INR (≈$1.9B) | 72 | 64 |
| 369 | 14.9B USD | 72 | 65 |
| 369 | 3.0B EUR (≈$3.3B) | 72 | 62 |
| 369 | 48.5B EUR (≈$53.4B) | 72 | 53 |